← Back Home

News Note · IDAEO AI News

#News media

10/27《生技股動態》-環球生技月刊

Original-language title

Published:

Publisher:

TL;DR · What this means

✔ 安基生技(7754)新藥AJ305獲得美國FDA正面回覆，得進行蟹足腫臨床一期試驗

(Excerpt from the original lead, not a rewrite)

Story Text

Full English translation is in progress; the text below is the original.

市場觀測：

✔ 安基生技(7754)新藥AJ305獲得美國FDA正面回覆，得進行蟹足腫臨床一期試驗

✔ 思必瑞特(7790)子公司取得日本核發特定細胞加工物等製造許可証

10/27一日漲跌

(漲)安克7.58%、達邦蛋白6.38%、沛爾生醫*-創4.91%

(跌)康霈*8.54%、雲象科技-創5.32%、福永生技4.9%

https://reurl.cc/yW89oy

10/27 法人動態

(買超)康霈*3510張、藥華藥364張、泰合226張；

(賣超)葡萄王280張、太景*-KY268張、松瑞藥262張

https://reurl.cc/1lVNMG

市場即時觀測：

http://bit.ly/bio-invest

新聞集錦

投資雷達

Citation-ready facts (F-Units)

✔ 安基生技(7754)新藥AJ305獲得美國FDA正面回覆，得進行蟹足腫臨床一期試驗

F1 Original sentence as captured by this site (only formatting marks and extra spaces removed), paragraph 2 · news.gbimonthly.com Source type: unclassified (not verified)

✔ 思必瑞特(7790)子公司取得日本核發特定細胞加工物等製造許可証

F2 Original sentence as captured by this site (only formatting marks and extra spaces removed), paragraph 3 · news.gbimonthly.com Source type: unclassified (not verified)

(漲)安克7.58%、達邦蛋白6.38%、沛爾生醫*-創4.91%

F3 Original sentence as captured by this site (only formatting marks and extra spaces removed), paragraph 5 · news.gbimonthly.com Source type: unclassified (not verified)

(跌)康霈*8.54%、雲象科技-創5.32%、福永生技4.9%

F4 Original sentence as captured by this site (only formatting marks and extra spaces removed), paragraph 6 · news.gbimonthly.com Source type: unclassified (not verified)

(買超)康霈*3510張、藥華藥364張、泰合226張；

F5 Original sentence as captured by this site (only formatting marks and extra spaces removed), paragraph 9 · news.gbimonthly.com Source type: unclassified (not verified)

Frequently Asked Questions (FAQ)

這則新聞的重點是什麼？

✔ 安基生技(7754)新藥AJ305獲得美國FDA正面回覆，得進行蟹足腫臨床一期試驗

原文提到哪些關鍵數字？

✔ 思必瑞特(7790)子公司取得日本核發特定細胞加工物等製造許可証 (漲)安克7.58%、達邦蛋白6.38%、沛爾生醫*-創4.91%

這則新聞的原始出處與發布時間？

原始出處：news.gbimonthly.com（https://news.gbimonthly.com/tw/invest/show.php?num=90929&kind=20）。原文發布時間：2026-10-27。

#News media